HomeERNA • NASDAQ
add
Eterna Therapeutics Inc
Previous close
$0.30
Day range
$0.29 - $0.31
Year range
$0.22 - $2.63
Market cap
15.43M USD
Avg Volume
1.68M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 487.00K | 854.90% |
Operating expense | 4.38M | -19.39% |
Net income | -26.60M | -375.84% |
Net profit margin | -5.46K | 50.17% |
Earnings per share | — | — |
EBITDA | -3.80M | 30.76% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.26M | -6.31% |
Total assets | 7.72M | -85.23% |
Total liabilities | 53.11M | 9.09% |
Total equity | -45.39M | — |
Shares outstanding | 51.37M | — |
Price to book | -0.04 | — |
Return on assets | -35.38% | — |
Return on capital | -58.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -26.60M | -375.84% |
Cash from operations | -6.28M | -7.88% |
Cash from investing | -19.00K | — |
Cash from financing | 3.89M | -54.48% |
Net change in cash | -2.42M | -189.06% |
Free cash flow | -1.36M | 20.28% |
About
Founded
1984
Headquarters
Website
Employees
8
